These findings, together with assessment of other biomarkers such as the autoimmune responses to insulin and S100B [9], may complement clinical investigations and be of importance as an aid for improved diagnostic accuracy of PD and as a tool to assess evolution of the disease as well as effects of interventions. Here, INS is linked to Parkinson disease.